Health In Tech, Inc. HIT
To change the non-transparent $5.3 trillion1 healthcare industry with innovation that removes friction and complexities with vertical integration, process simplification,
automation, and digitalization.
platform company, which offers a marketplace that improves processes in the healthcare industry through vertical integration, process
simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $37.6M | $19.6M | $19.2M | — |
| Cost of revenue | $12.4M | $4.1M | $2.3M | — |
| Gross profit | $20.9M | $15.4M | $16.8M | — |
| R&D | $1.6M | $2.8M | $2.0M | — |
| SG&A | $13.7M | $8.5M | $8.1M | — |
| Total operating expenses | $19.4M | $14.4M | $13.5M | — |
| Interest expense | — | $495.0K | $495.0K | — |
| Pre-tax income | $1.7M | $889.0K | $3.4M | — |
| Income tax | $395.3K | $218.5K | $945.2K | — |
| Net income | $1.3M | $670.5K | $4.0M | — |
| EPS, basic | 0.02 | 0.01 | — | — |
| EPS, diluted | 0.02 | 0.01 | — | — |
| Shares, diluted (wtd. avg.) | $57.7M | $53.7M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | $7.7M | $7.8M | $2.4M | $1.5M |
| Receivables | $756.3K | $1.6M | $2.2M | — |
| Total current assets | $16.2M | $10.8M | $6.9M | — |
| Total assets | $23.1M | $15.8M | $11.5M | — |
| Accounts payable | $4.2M | $1.9M | $2.6M | — |
| Total current liabilities | $5.2M | $2.1M | $4.8M | — |
| Total liabilities | $6.0M | $2.6M | $5.4M | — |
| Retained earnings | $5.2M | $3.9M | $3.3M | — |
| Total equity | $17.1M | $13.2M | $6.1M | $1.4M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating cash flow | $3.1M | $2.2M | $1.5M | — |
| Depreciation and amortisation | $900.6K | $541.1K | — | — |
| Stock-based compensation | $1.6M | $468.5K | — | — |
| Investing cash flow | -$3.1M | -$836.8K | -$1.9M | — |
| Financing cash flow | -$187.4K | $4.1M | $1.3M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-034211.
Others in SIC 6411
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MRSH | MARSH & MCLENNAN COMPANIES, INC. | $88.64B | 22.0x | 10.3% |
| AON | Aon plc | $68.54B | 19.0x | 9.4% |
| AJG | Arthur J. Gallagher & Co. | $67.33B | 45.8x | 20.7% |
| WTW | WILLIS TOWERS WATSON PLC | $31.09B | 20.6x | -2.3% |
| BRO | BROWN & BROWN, INC. | $23.90B | 22.6x | 22.8% |
| EQH | Equitable Holdings, Inc. | $14.46B | — | -6.1% |
| ACT | Enact Holdings, Inc. | $6.77B | 10.9x | 2.8% |
| NP | Neptune Insurance Holdings Inc. | $4.58B | — | 33.7% |